News

Filter

Current filters:

ShireResearch

1 to 9 of 32 results

GlobalData believes Shire-NPS deal to be 'robust'

GlobalData believes Shire-NPS deal to be 'robust'

15-01-2015

Ireland-headquartered drugmaker Shire’s deal to acquire NPS Pharmaceuticals is ‘robust’, according…

GattexGlobalDataMergers & AcquisitionsNatparaNPS PharmaceuticalsPharmaceuticalRare diseasesResearchShire

Shire exercises option on candidates from arGEN-X collaboration

Shire exercises option on candidates from arGEN-X collaboration

11-12-2014

Ireland-headquartered drugmaker Shire has exercised the option to advance into preclinical development…

arGEN-XLicensingPharmaceuticalResearchShire

Shire in $15 million research collaboration with CFFT on novel CF treatment; pipeline news

Shire in $15 million research collaboration with CFFT on novel CF treatment; pipeline news

10-12-2014

Cystic Fibrosis Foundation Therapeutics Inc, the non-profit drug discovery and development affiliate…

LifitegrastOphthalmicsPharmaceuticalRare diseasesResearchShireSHP607SHP625SHP626Vyvanse

Shire's guanfacine hydrochloride extended release reduces core ADHD symptoms in Phase III trial

Shire's guanfacine hydrochloride extended release reduces core ADHD symptoms in Phase III trial

10-12-2014

Ireland-headquartered drugmaker Shire has achieved positive results in a Phase III trial of guanfacine…

Guanfacine HydrochlorideIrelandNeurologicalPharmaceuticalResearchShire

Shire agrees to FDA call for pediatric trials of Vyvanse for ADHD

Shire agrees to FDA call for pediatric trials of Vyvanse for ADHD

12-06-2014

Ireland-headquartered drugmaker Shire says it has agreed to a written request by the US Food and Drug…

NeurologicalPharmaceuticalRegulationResearchShireUSAVyvanse

arGEN-X and Shire sign long term collaboration deal worth $20 million

arGEN-X and Shire sign long term collaboration deal worth $20 million

04-06-2014

Belgium-based preclinical stage biotech firm arGEN-X has entered into a long-term strategic alliance…

arGEN-XBiotechnologyBusiness FinanceEuropeHuman antibody discovery technologiesResearchShireShire Pharmaceuticals

Shire 1st-qrt 2014 sales and earnings rocket; lifitegrast disappoints

01-05-2014

Ireland-headquartered drugmaker Shire posted a strong set of financials this afternoon, showing that…

FinancialLifitegrastOphthalmicsPharmaceuticalRare diseasesResearchShire

Shire will drop MDD indication for Vyvanse after failed endpoints in Ph III

07-02-2014

Shares of Ireland-headquartered Shire fell 2.4% to £30.67 in early trading, after the company presented…

NeurologicalPharmaceuticalResearchShireVyvanse

1 to 9 of 32 results

Back to top